A detailed history of Vident Advisory, LLC transactions in Insmed Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 4,937 shares of INSM stock, worth $363,856. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,937
Previous 3,625 36.19%
Holding current value
$363,856
Previous $265 Million 28.8%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$66.29 - $76.63 $86,972 - $100,538
1,312 Added 36.19%
4,937 $341 Million
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $224,750 - $286,411
3,625 New
3,625 $265 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.